1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
- Contribution to journal › Article
-
Mark
Validation of a breast cancer assay for radiotherapy omission : an individual participant data meta-analysis
- Contribution to journal › Article
-
Mark
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
- Contribution to journal › Article
- 2024
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
- Contribution to journal › Article
- 2023
-
Mark
Reply to V. Nardone et al
- Contribution to journal › Debate/Note/Editorial
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
- Contribution to journal › Article
- 2022
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
- Contribution to journal › Article
- 2021
-
Mark
Immune infiltrate in the primary tumor predicts effect of adjuvant radiotherapy in breast cancer : Results from the randomized SweBCG91RT trial
- Contribution to journal › Article
- 2020
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
- 2019
-
Mark
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
- Contribution to journal › Article
